These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34841034)

  • 1. Codon usage, phylogeny and binding energy estimation predict the evolution of SARS-CoV-2.
    Calcagnile M; Verri T; Tredici MS; Forgez P; Alifano M; Alifano P
    One Health; 2021 Dec; 13():100352. PubMed ID: 34841034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation.
    Rodriguez JA; Gonzalez J; Arboleda-Bustos CE; Mendoza N; Martinez C; Pinzon A
    Chem Biol Interact; 2022 Dec; 368():110244. PubMed ID: 36336003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codon usage divergence in Delta variants (B.1.617.2) of SARS-CoV-2.
    Li G; Zhang L; Xue P
    Infect Genet Evol; 2022 Jan; 97():105175. PubMed ID: 34871776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural selection plays a significant role in governing the codon usage bias in the novel SARS-CoV-2 variants of concern (VOC).
    Tyagi N; Sardar R; Gupta D
    PeerJ; 2022; 10():e13562. PubMed ID: 35765592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
    Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
    mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
    Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
    Elife; 2021 Aug; 10():. PubMed ID: 34435953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction.
    Mollentze N; Keen D; Munkhbayar U; Biek R; Streicker DG
    Elife; 2022 Nov; 11():. PubMed ID: 36416537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key mutations on spike protein altering ACE2 receptor utilization and potentially expanding host range of emerging SARS-CoV-2 variants.
    Wang Q; Ye SB; Zhou ZJ; Li JY; Lv JZ; Hu B; Yuan S; Qiu Y; Ge XY
    J Med Virol; 2023 Jan; 95(1):e28116. PubMed ID: 36056469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes.
    Guo H; Hu BJ; Yang XL; Zeng LP; Li B; Ouyang S; Shi ZL
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32699095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and computational analysis of spike protein of newly emerged omicron variant in comparison to the delta variant of SARS-CoV-2 in Iraq.
    Rashid PMA; Salih GF
    Mol Biol Rep; 2022 Aug; 49(8):7437-7445. PubMed ID: 35698014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach.
    Zaheer M; Ali N; Javed H; Munir R; Jamil N
    J Infect Public Health; 2023 Oct; 16(10):1544-1555. PubMed ID: 37566991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host adaptation of codon usage in SARS-CoV-2 from mammals indicates potential natural selection and viral fitness.
    Fu Y; Huang Y; Rao J; Zeng F; Yang R; Tan H; Liu Z; Du W; Liu L
    Arch Virol; 2022 Dec; 167(12):2677-2688. PubMed ID: 36166106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking SARS-CoV-2 Delta Variant (B.1.617.2) Spike Protein Receptor-Binding Domain Binding with the ACE2 Receptor of the Host Cell and Inhibiting Virus Infections Using Human Host Defense Peptide-Conjugated Graphene Quantum Dots.
    Pramanik A; Sharma PC; Patibandla S; Gao Y; Ruppa-Kasani V; Goli J; Kumar A; Chatterjee A; Sinha SS; Bates JT; Bierdeman MA; Tandon R; Ray PC
    ACS Omega; 2022 Mar; 7(9):8150-8157. PubMed ID: 35252734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Betacoronaviruses genome analysis reveals evolution toward specific codons usage: Implications for SARS-CoV-2 mitigation strategies.
    Lopes EN; Fonseca V; Frias D; Tosta S; Salgado Á; Assunção Vialle R; Paulo Eduardo TS; Barreto FK; Ariston de Azevedo V; Guarino M; Angeletti S; Ciccozzi M; Junior Alcantara LC; Giovanetti M
    J Med Virol; 2021 Sep; 93(9):5630-5634. PubMed ID: 33934387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxalic acid blocked the binding of spike protein from SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variants to human angiotensin-converting enzymes 2.
    Wang M; Yan H; Chen L; Wang Y; Li L; Zhang H; Miao L
    PLoS One; 2023; 18(5):e0285722. PubMed ID: 37200310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Synthetic Biology Approach for Vaccine Candidate Design against Delta Strain of SARS-CoV-2 Revealed Disruption of Favored Codon Pair as a Better Strategy over Using Rare Codons.
    Gurjar P; Karuvantevida N; Rzhepakovsky IV; Khan AA; Khandia R
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peimine inhibits variants of SARS-CoV-2 cell entry via blocking the interaction between viral spike protein and ACE2.
    Wang WJ; Chen Y; Su WC; Liu YY; Shen WJ; Chang WC; Huang ST; Lin CW; Wang YC; Yang CS; Hou MH; Chou YC; Wu YC; Wang SC; Hung MC
    J Food Biochem; 2022 Oct; 46(10):e14354. PubMed ID: 35894128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE2 receptor polymorphism in humans and animals increases the risk of the emergence of SARS-CoV-2 variants during repeated intra- and inter-species host-switching of the virus.
    Devaux CA; Fantini J
    Front Microbiol; 2023; 14():1199561. PubMed ID: 37520374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.